Patindol, Francisco T.

HRN: 26-10-33  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/09/2026
05/16/2026
IV
2.25G
Q6H
SEPSIS PROB SEC TO COMPLICATED UTI
Checking Initial Appropriateness 

 Indication:  Empiric Then Culture-directed    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines